Beam Therapeutics Operating margin
What is the Operating margin of Beam Therapeutics?
The Operating margin of Beam Therapeutics Inc. is -52.31%
What is the definition of Operating margin?
Operating margin is the ratio of operating income divided by net sales and presented in percent.
ttm (trailing twelve months)
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Operating margin of companies in the Health Care sector on NASDAQ compared to Beam Therapeutics
What does Beam Therapeutics do?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Companies with operating margin similar to Beam Therapeutics
- CCT Fortis has Operating margin of -52.55%
- Peijia Med Ltd has Operating margin of -52.47%
- Facebank has Operating margin of -52.43%
- Vita has Operating margin of -52.41%
- Elmo Software has Operating margin of -52.36%
- Elmo Software has Operating margin of -52.36%
- Beam Therapeutics has Operating margin of -52.31%
- SuperRobotics has Operating margin of -52.15%
- Pure Minerals has Operating margin of -52.14%
- Okta has Operating margin of -52.12%
- Uscom has Operating margin of -52.09%
- Pinestone Capital has Operating margin of -52.05%
- Morris has Operating margin of -52.05%